Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2020-10-26
2022-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this proposed research is to conduct a feasibility trial to assess the acceptability, levels of engagement, and preliminary efficacy of an integrated program that combines text-messaging for smoking cessation and text messages providing proactive linkage to the quitline compared to a single passive quitline text message referral among DCHA residents. The investigators hypothesize that the integrated program (combining text messages for smoking cessation and proactive quitline linkage) will yield significantly higher rates of quit attempts than passive quitline referral only.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Smoke-free Home Study in Subsidized Housing
NCT06170437
Interventions to Help More Low-income Smokers Quit
NCT04311983
Brief Interventions to Create Smoke-Free Home Policies in Low-Income Households
NCT01625468
Study of Mobile Phone Support for the DC Tobacco Quitline
NCT01817842
Durham Housing Authority (DHA) Community Health Advisor (CHA) Smoking Cessation Project
NCT04114526
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Smoking cessation + quitline linkage text messages
Text messaging for smoking cessation + text messages with proactive linkage to quitline
Smoking cessation + quitline linkage text messages
Smoking cessation text messages will provide behavioral skills and support for quitting smoking. Quitline linkage text messages will include contact information for the quitline, option to be contacted by the quitline and active referral to the quitline upon setting a Quit Date.
Passive quitline referral
Single text message with contact information for the Quitline
Passive quitline referral
Single text message with contact information for the Quitline
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Smoking cessation + quitline linkage text messages
Smoking cessation text messages will provide behavioral skills and support for quitting smoking. Quitline linkage text messages will include contact information for the quitline, option to be contacted by the quitline and active referral to the quitline upon setting a Quit Date.
Passive quitline referral
Single text message with contact information for the Quitline
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* resident of D.C. public housing
* smoked a cigarette in the 7 days prior to screening (self-report)
* has daily access to a working cell phone with an unlimited text message plan
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
George Washington University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lorien Abroms
PI
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
George Washington University
Washington D.C., District of Columbia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCR191457
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.